May 12, 2016
HealthCap’s 35th IPO as HealthCap VI company Wilson Therapeutics completes listing on Nasdaq OMX Stockholm
Media
May 12, 2016
Targovax ASA: Interim report first quarter 2016
May 09, 2016
Nordic Nanovector announces an open Investigational New Drug application for new clinical study of Betalutin® in diffuse large B-cell lymphoma
May 05, 2016
Strongbridge Biopharma plc Announces Presentation at Bio€quity Europe 2016
May 04, 2016
Nordic Nanovector announces first patient enrolled in Arm 3 of expanded Phase 1/2 study of Betalutin® in NHL patients
May 03, 2016
Q1 2016 General Market Overview
April 29, 2016
WILSON THERAPEUTICS ANNOUNCES INITIAL PUBLIC OFFERING ON NASDAQ STOCKHOLM
April 21, 2016
Interim Report January-March 2016
April 21, 2016
Nexstim Plc announces the change of CEO
April 20, 2016
SAVE THE DATE – NORDIC NANOVECTOR CAPITAL MARKETS DAY
